Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

MLA

Jean, Shio-Shin, et al. “Rates of Susceptibility of Carbapenems, Ceftobiprole, and Colistin against Clinically Important Bacteria Collected from Intensive Care Units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).” Journal of Microbiology, Immunology and Infection, vol. 49, no. 6, Dec. 2016, pp. 969–76. EBSCOhost, https://doi.org/10.1016/j.jmii.2014.12.008.

APA

Jean, S.-S., Lee, W.-S., Yu, K.-W., Liao, C.-H., Hsu, C.-W., Chang, F.-Y., Ko, W.-C., Chen, R.-J., Wu, J.-J., Chen, Y.-H., Chen, Y.-S., Liu, J.-W., Lu, M.-C., Lam, C., Liu, C.-Y., & Hsueh, P.-R. (2016). Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). Journal of Microbiology, Immunology and Infection, 49(6), 969–976. https://doi.org/10.1016/j.jmii.2014.12.008

Chicago

Jean, Shio-Shin, Wen-Sen Lee, Kwok-Woon Yu, Chun-Hsing Liao, Chin-Wang Hsu, Feng-Yi Chang, Wen-Chien Ko, et al. 2016. “Rates of Susceptibility of Carbapenems, Ceftobiprole, and Colistin against Clinically Important Bacteria Collected from Intensive Care Units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).” Journal of Microbiology, Immunology and Infection 49 (6): 969–76. doi:10.1016/j.jmii.2014.12.008.